We identified Siglec-15 as a critical immune suppressor with broad upregulation on various cancer types and a potential target for cancer immunotherapy
6months Applications Used for the detection and quantification of 4-Coumarate CoA Ligase activity
KGF Accession P21781 Amino Acid Sequence Cys32-Thr194 Expression System E
including inflammatory stimuli
-20℃ as supplied
α/β-Synuclein Recombinant Rabbit mAb (S-309-72) Size:100μl We identified Siglec-15 as aProduct Specification Host Rabbit Antigen Synuclein Synonyms Non A beta component of AD amyloid, Non A4 component of amyloid precursor (NACP), SNCA, PARK1, SNCB Immunogen Synthetic Peptide Location Cytoplasm, Nucleus, Secreted Accession P37840 Q16143 Clone Number S 309 72 Antibody Type Recombinant mAb Application WB, IHC P, IP Reactivity Hu, Ms, Rt Predicted Reactivity Av, Bv, Pr, Mq, Pg, Or Purification Protein A Concentration 0. 25 mg ml Conjugation